new_0222_0720|CMMB|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0720|CMMB|Long Name|1|1|Chemomab Therapeutics Ltd Total Current Assets (Quarterly) (USD)|Chemomab Therapeutics Ltd Cash and Short Term Investments (Quarterly) (USD)|Chemomab Therapeutics Ltd Inventories (Quarterly) (USD)|Chemomab Therapeutics Ltd Net PP&E (Quarterly) (USD)|Chemomab Therapeutics Ltd Goodwill and Intangibles (Quarterly) (USD)|Chemomab Therapeutics Ltd Total Liabilities (Quarterly) (USD)|Chemomab Therapeutics Ltd Total Current Liabilities (Quarterly) (USD)|Chemomab Therapeutics Ltd Total Long Term Liabilities (Quarterly) (USD)|Chemomab Therapeutics Ltd Total Deposits (Quarterly) (USD)|Chemomab Therapeutics Ltd Book Value (Quarterly) (USD)|Chemomab Therapeutics Ltd Retained Earnings (Quarterly) (USD)|Chemomab Therapeutics Ltd Treasury Stock (Quarterly) (USD)|Chemomab Therapeutics Ltd EV to Revenues|Chemomab Therapeutics Ltd EV to Earnings|Chemomab Therapeutics Ltd EV to Free Cash Flow|Chemomab Therapeutics Ltd EV to Assets (Quarterly)|Chemomab Therapeutics Ltd PS Ratio|Chemomab Therapeutics Ltd PE Ratio|Chemomab Therapeutics Ltd Price to Book Value|Chemomab Therapeutics Ltd PEG Ratio|Chemomab Therapeutics Ltd Debt to Equity Ratio|Chemomab Therapeutics Ltd Dividend Yield|Chemomab Therapeutics Ltd Shareholder Yield (TTM)|Chemomab Therapeutics Ltd Percent of Shares Outstanding Short|Chemomab Therapeutics Ltd Total Receivables (Quarterly) (USD)|Chemomab Therapeutics Ltd Total Payables (Quarterly) (USD)|Chemomab Therapeutics Ltd Total Capital Stock (Quarterly) (USD)|Chemomab Therapeutics Ltd Return on Invested Capital|Chemomab Therapeutics Ltd Quality Ratio Score|Chemomab Therapeutics Ltd Momentum Score|Chemomab Therapeutics Ltd Beta (1Y)|Chemomab Therapeutics Ltd Sustainable Growth Rate (TTM)|Chemomab Therapeutics Ltd Institutional Investor Ownership Percentage|Chemomab Therapeutics Ltd Average Diluted Shares Outstanding (Quarterly)|Chemomab Therapeutics Ltd Total Employees (Annual)|Chemomab Therapeutics Ltd EPS Diluted (Quarterly) (USD)|Chemomab Therapeutics Ltd Shares Outstanding|Chemomab Therapeutics Ltd Repurchase of Capital Stock (Quarterly) (USD)|Chemomab Therapeutics Ltd Ordinary Shares Number (Quarterly)|Chemomab Therapeutics Ltd Payout Ratio|Chemomab Therapeutics Ltd Quick Ratio (Quarterly)|Chemomab Therapeutics Ltd Normalized Diluted EPS (Quarterly) (USD)|Chemomab Therapeutics Ltd Stock Buybacks (Quarterly) (USD)|Chemomab Therapeutics Ltd Effective Tax Rate (TTM)|Chemomab Therapeutics Ltd Return on Equity|Chemomab Therapeutics Ltd Net Income (TTM) (USD)|Chemomab Therapeutics Ltd Revenue (TTM) (USD)|Chemomab Therapeutics Ltd Dividend Per Share (Quarterly) (USD)|Chemomab Therapeutics Ltd Revenue (Quarterly) (USD)|Chemomab Therapeutics Ltd Gross Profit (Quarterly) (USD)|Chemomab Therapeutics Ltd SG&A Expense (Quarterly) (USD)|Chemomab Therapeutics Ltd Pre-Tax Income (Quarterly) (USD)|Chemomab Therapeutics Ltd Net Income (Quarterly) (USD)|Chemomab Therapeutics Ltd Net Interest Income (Quarterly) (USD)|Chemomab Therapeutics Ltd Price (USD)|Chemomab Therapeutics Ltd Total Return Price (USD)|Chemomab Therapeutics Ltd Enterprise Value (USD)|Chemomab Therapeutics Ltd 30-Day Average Daily Volume|Chemomab Therapeutics Ltd 1 Year Price Returns (Daily)
new_0222_0720|CMMB|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0720|CMMB||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0720|CMMB||5|5|91.5|91.5|0|91.5|0|91.5|91.5|91.5|0|91.5|91.5|0|0|0|1.43352601156|0|0|0|1.43103448276|0|0|1.44678055191|0|15.3333333333|91.5|91.5|91.5|0|0|31.9523809524|30.5217391304|0|30.7142857143|109.6|0|109.6|37.75|0|91.5|0|0|109.6|109.6|0|0|91.5|0|0|0|0|109.6|109.6|109.6|109.6|6.9746835443|6.9746835443|1.43352601156|6.96710526316|1.44597249509
new_0222_0720|CMMB||6|6|2|2|0|2|0|2|2|2|0|2|2|0|0|0|173|0|0|0|174|0|0|761|0|15|2|2|2|0|0|21|23|0|7|5|0|5|4|0|2|0|0|5|5|0|0|2|0|0|0|0|5|5|5|5|158|158|173|152|509
new_0222_0720|CMMB||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0720|CMMB|201902|201812|201812||||||||||||||||||||||0|||||||||||||||||||||||||||||||||131.2|131.2|||
new_0222_0720|CMMB|201903|201903|201903||||||||||||||||||||||0|||||||||||||||||||||||||||||||||108|108||41740.5667|
new_0222_0720|CMMB|201904|201903|201903||||||||||||||||||||||0|||||||||||||||||||||||||||||||||93.2|93.2||10480.8667|
new_0222_0720|CMMB|201905|201903|201903||||||||||||||||||||||0|||||||||||||||||||||||||||||||||76.7264|76.7264||3968|
new_0222_0720|CMMB|201906|201906|201906||||||||||||||||||||||0|||||||||||||||||||||||||||||||||68|68||5100.4333|
new_0222_0720|CMMB|201907|201906|201906||||||||||||||||||||||0|||||||||||||||||||||||||||||||||50.48|50.48||6076.6|
new_0222_0720|CMMB|201908|201906|201906||||||||||||||||||||||0|||||||||||||||||||||||||||||||||36.6384|36.6384||27286.1667|
new_0222_0720|CMMB|201909|201909|201909||||||||||||||||||||||0|||||||||||||||||||||||||||||||||42.56|42.56||57584.4|
new_0222_0720|CMMB|201910|201909|201909||||||||||||||||||||||0|||||||||||||||||||||||||||||||||35.52|35.52||30934.2667|
new_0222_0720|CMMB|201911|201909|201909||||||||||||||||||||||0|||||||||||||||||||||||||||||||||21.2192|21.2192||30836.4|
new_0222_0720|CMMB|201912|201912|201912||||||||||||||||||||||0|||||||||||||||||||||||||||||||||22.4|22.4||36354.9667|
new_0222_0720|CMMB|202001|201912|201912||||||||||||||||||||||0|||||||||||||||||||||||||||||||||21.6|21.6||46877.5667|
new_0222_0720|CMMB|202002|201912|201912||||||||||||||||||||||0|||||||||0.6736||||||||||||||||||||||||19.5872|19.5872||34848.8|-88.7688
new_0222_0720|CMMB|202003|202003|202003||||||||||||||||||||||0||||||||1|0.2754|||11.0029||-0.154||||||-0.154|0||||||||0.152|-1.695|-1.695|0.009|12.576|12.576||25592.3667|-88.4327
new_0222_0720|CMMB|202004|202003|202003||||||||||||||||||||||0||||||||1|0.9052||||||||||||||||||||||||12.8|12.8||21342.1|-84.6592
new_0222_0720|CMMB|202005|202003|202003||||||||||||||||||||||0||||||||1|1.227||||||||||||||||||||||||18.24|18.24||52266.9333|-77.5967
new_0222_0720|CMMB|202006|202006|202006||||||||||||||||||||||0||||||||1|1.4254|||11.0029||-0.0982||||||-0.0982|-3||||||||0.254|-1.081|-1.081|0.02|21.92|21.92||93399.1|-69.4196
new_0222_0720|CMMB|202007|202006|202006||||||||||||||||||||||0||||||||1|1.1586||||||||||||||||||||||||14.528|14.528||110813.5333|-67.4343
new_0222_0720|CMMB|202008|202006|202006||||||||||||||||||||||0||||||||1|1.1206||||||||||||||||||||||||16.8|16.8||120605.5333|-60.3806
new_0222_0720|CMMB|202009|202009|202009||||||||||||||||||||||0||||||||2|0.8363|||11.0029||-0.1112||||||-0.1112|0||||||||0.194|-1.224|-1.224|0.001|19.04|19.04||50909.8333|-50.4197
new_0222_0720|CMMB|202010|202009|202009||||||||||||||||||||||0||||||||2|0.6909||||||||||||||||||||||||18.88|18.88||557182.8|-41.8919
new_0222_0720|CMMB|202011|202009|202009||||||||||||||||||||||0||||||||2|1.0666||||||||||||||||||||||||24|24||891090.2667|10.6383
new_0222_0720|CMMB|202012|202012|202012||||||||||||||||||||||0||||||||7|1.0977||||||||||||||||||||||||32|32||3341300.2667|23.5714
new_0222_0720|CMMB|202101|202012|202012||||||||||||||||||||||0||||||||8|0.9887||||||||||||||||||||||||38.24|38.24||3433626.7333|54.6468
new_0222_0720|CMMB|202102|202012|202012||||||||||||||||||||||0||||||||8|0.477||||||||||||||||||||||||60.16|60.16||2164591.5|259.4059
new_0222_0720|CMMB|202103|202103|202103|59.523|58.203||0.545||4.959|4.631|0.328||55.164|-25.399|||||||||||0|||0.32|2.083|0|||9|-0.8276|||7.8376||-0.22|||227.9561|||-0.22|-45.372|||-5.704|||||0.542|-1.704|-1.704|-0.005|28.78|28.78||3201761.8667|128.292
new_0222_0720|CMMB|202104|202103|202103||||||||||||||||||||||0||||||||8|-1.3754||||||||||||||||||||||||34.26|34.26||1081257.7333|106.748
new_0222_0720|CMMB|202105|202103|202103||||||||||||||||||||||0|||||||||-0.8885||||||||||||||||||||||||16.07|16.07||273837.3333|-0.3378
new_0222_0720|CMMB|202106|202106|202106|68.835|66.92||0.635||2.479|2.159|0.32||68.039|-28.169||||-17.0186||||3.1862|||0||0.1911|1.915|0.472|0|||2|-0.8017||32.5897|10.8133||-0.26|11.3978||227.9561|||-0.26|-13.428|||-6.779|||||1.446|-2.77|-2.77|-0.017|19.21|19.21|149.8662|533865.2333|-13.2299
new_0222_0720|CMMB|202107|202106|202106|||||||||||||||-13.9252||||2.7858|||0||0.2789||||||2|-0.2845||34.2208||||||||||||||||||||||16.31|16.31|122.6254|322309.9|10.5717
new_0222_0720|CMMB|202108|202106|202106|||||||||||||||-11.3883||||2.4575|||0||0.725||||||4|-0.27||34.1893||||||||||||||||||||||14.67|14.67|100.2857|150510.4667|-6.3075
new_0222_0720|CMMB|202109|202109|202109|65.842|64.268||0.593||1.928|1.63|0.298||65.512|-31.137||||-5.9033||||1.9277|||0||0.1761|1.574|0.481|0|||3|1.2853||29.9484|11.3978||-0.26|11.3978||227.9561|||-0.26|0.072|||-8.666|||||1.404|-2.968|-2.968|-0.077|11.95|11.95|62.0196|107698.9667|-39.2544
new_0222_0720|CMMB|202110|202109|202109|||||||||||||||-4.7829||||1.748|||0||0.5538||||||2|1.5429||29.9382||||||||||||||||||||||9.81|9.81|50.2491|126878.2|-47.2306
new_0222_0720|CMMB|202111|202109|202109|||||||||||||||-3.9206||||1.6097|||0||0.2739||||||1|0.7802||29.9363||||11.4008||||||||||||||||||9.25|9.25|41.1894|213730.4333|-62.9407
new_0222_0720|CMMB|202112|202112|202112|||||||||||||||-1.3704||||1.2008|||0||0.236||||||1|0.0936||29.9698||||||||||||||||||||||7.05|7.05|14.3975|168249.9667|-75.0723
new_0222_0720|CMMB|202201|202112|202112|||||||||||||||0.7999||||0.8527|||0||0.1978||||||1|1.5819||28.821||||||||||||||||||||||5.22|5.22|-8.4041|126863.5333|-85.2764
new_0222_0720|CMMB|202202|202112|202112|||||||||||||||1.5921||||0.663|||0|||||||||||||||||||||||||||||||||3.81|3.81|-16.7267|69686.3333|-94.4179